SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Oruka Therapeutics, Inc.
@ORKA_InsiderForm 4 Filing: Agarwal Arjun Sells $128,468.235 of $ORKA
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Oruka Therapeutics, Inc.
Ticker: $ORKA
Transaction Value
$128,468.235
Price/Share: $80.95
transaction date
2026-06-22
Shares: 1,587
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Agarwal Arjun, holds the title of Senior Vice President, Finance at Oruka Therapeutics, Inc..
On 2026-06-22, the insider transacted 1,587 shares.The shares were transacted at a weighted average price of $80.95 per share, resulting in a total market-relevant value of $128,468.235.
Executive Summary Summary
Agarwal Arjun (Senior Vice President, Finance) sold $128K of $ORKA
Post-Transaction Position: 16,011 shares
SEC Accession No: 0000907654-26-000066 (CIK: 2033974)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.